Closing Keynote Session | Beyond the Pandemic - How COVID-19 Transformed Clinical Trials and Data Management (with Dr. Sara Brenner, FDA Principal Deputy Commissioner)

The COVID-19 pandemic fundamentally reshaped how we conduct clinical research, from accelerated timelines to remote monitoring capabilities. Dr. Brenner, who played a pivotal role in the FDA's COVID-19 diagnostic response, will examine the transformative changes that emerged from necessity and how these innovations must evolve to define the future of clinical trials.

Key Topics:

• Revolutionary changes in clinical trial design and execution during COVID-19
• Data quality lessons learned from emergency use authorization pathways
• Remote monitoring, decentralized trials, and digital transformation insights
• Regulatory flexibility versus scientific rigor - finding the sustainable balance
• Building resilient clinical data systems for future public health emergencies

Drawing from her frontline experience with diagnostic innovation and regulatory policy during the pandemic, Dr. Brenner will challenge attendees to preserve the best pandemic-driven innovations while strengthening the foundations of clinical research for tomorrow's challenges.